Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatocellular carcinoma
Phenotype C0019163|hepatitis b
Sentences 147
PubMedID- 25735064 A 65-year-old woman had previously undergone ldlt for hepatocellular carcinoma associated with hepatitis b virus infection.
PubMedID- 24023999 A 49 year-old woman (160.0 cm, 94.6 kg) suffering from hepatocellular carcinoma with end-stage hepatitis b liver cirrhosis (model for end stage liver disease [meld] score 14, child-pugh class b) presented for living donor lt. she had hypertension that was well controlled with medications.
PubMedID- 21459723 Gpc3 fused to an alpha epitope of hbsag acts as an immune target against hepatocellular carcinoma associated with hepatitis b virus.
PubMedID- 24405714 [41] showed that the expression level of mir-122 continues to decrease in hepatocellular carcinoma with chronic hepatitis b viral infection compared with preoperative and healthy people.
PubMedID- 22444598 Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis b infection.
PubMedID- 23945731 Random-effects inverse variance meta-analysis of antiviral therapy treatment effects on hepatocellular carcinoma in patients with chronic hepatitis b and cirrhosis, subgroups according to trial design.
PubMedID- 21497551 Background: therapy for chronic hepatitis b reduces the risk of progressing to hepatocellular carcinoma (hcc); however, there is no suitable and accurate means to assess risk.
PubMedID- 25521761 Here, we profiled the mutations and gene expressions of early and advanced hepatocellular carcinoma (hcc) related with hepatitis b-viral infection.
PubMedID- 23586065 To evaluate the possible association between the vitamin d receptor (vdr), single-nucleotide polymorphisms (snps), and hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection.
PubMedID- 20368541 This study aimed to develop nomograms for predicting hepatocellular carcinoma risk in patients with chronic hepatitis b.
PubMedID- 26159441 Background: this study was designed to evaluate the prognostic value of three systemic inflammation markers, neutrophil to lymphocyte ratio (nlr), platelet to lymphocyte ratio (plr), and prognostic nutritional index (pni), for hepatocellular carcinoma (hcc) associated with hepatitis b (hbv).
PubMedID- 21104161 Association of novel mutations and haplotypes in the pres region of hepatitis b virus with hepatocellular carcinoma.
PubMedID- 25945007 Aim: to clarify the utility of using des-gamma-carboxy prothrombin (dcp) and alpha-fetoprotein (afp) levels to predict the prognosis of hepatocellular carcinoma (hcc) in patients with hepatitis b virus (hbv) and the hepatitis c virus (hcv) infections.
PubMedID- 20976853 A 51-year-old chinese male with a 20-year history of hepatitis b was diagnosed with hepatocellular carcinoma in the right anterior portion of the liver, sized 3.5 cm x 3.2 cm, and was treated with radiofrequency ablation (rfa) on december 18, 2001.
PubMedID- 21160825 Skull metastasis from hepatocellular carcinoma with chronic hepatitis b.
PubMedID- 22043780 The authors hereby report a 9-year-old girl with hepatocellular carcinoma associated with positive hepatitis b surface antigen at queen sirikit national institute of child health.
PubMedID- 24583062 Background & aims: little is known about whether the antiviral agent entecavir is more effective than a less potent drug, lamivudine, in reducing the risk of death and hepatocellular carcinoma (hcc) in patients with chronic hepatitis b.
PubMedID- 21319289 Second neoplasms appeared in 3 patients, 1 of whom died of hepatocellular carcinoma following infection with hepatitis b.
PubMedID- 25873850 The present case was a young man, a known case of chronic hepatitis b with multiple recurrent hepatocellular carcinoma, who presented with clinical sepsis and jaundice.
PubMedID- 24704525 Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis b: a nationwide cohort study.
PubMedID- 25569223 Blood gene signature for early hepatocellular carcinoma detection in patients with chronic hepatitis b.
PubMedID- 25803433 Tsan et al used this definition to study statins and the risk of hepatocellular carcinoma in patients with hepatitis b virus infection [24].
PubMedID- 24393929 A 61-year-old man who complained of right hypochondralgia was diagnosed as hepatocellular carcinoma (hcc) associated with hepatitis b virus (hbv) infection.
PubMedID- 24187458 Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis b.
PubMedID- 25442807 An adolescent female having hepatocellular carcinoma associated with hepatitis b virus genotype h with a deletion mutation in the pre-s2 region.
PubMedID- 25921128 Cyp2c19 genotype could be a predictive factor for aggressive manifestations of hepatocellular carcinoma related with chronic hepatitis b infection in thailand.
PubMedID- 23663868 A 57 year-old man with hepatitis b was diagnosed with hepatocellular carcinoma post-liver transplant with subsequent liver, lung and bone metastases.
PubMedID- 20384529 Objective: the aim of this nationwide cohort study was to assess the risk for hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection or hbv and hepatitis c virus (hcv) co-infection in sweden, a low endemic country.
PubMedID- 23326448 Patients had no other causes of liver disease, autoimmune or metabolic disorders, hepatocellular carcinoma and coinfection with hepatitis b virus and/or human immunodeficiency virus.
PubMedID- 26211878 A19-year-old man volunteered for living donation to his father who suffered from hepatitis b virus-related cirrhosis of liver and hepatocellular carcinoma.
PubMedID- 25312649 The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis b on long-term nucleos(t)ide analogue therapy.
PubMedID- 23237253 The article reviewed here reports on the prognostic role of liver stiffness as measured by transient elastography and other noninvasive methods in the prediction of clinical decompensation and hepatocellular carcinoma in patients with chronic hepatitis b.
PubMedID- 25915736 In a population-based study examining hdac10 polymorphisms it was found that one variant that resulted in increased expression of hdac10 protein also corresponded with an increased occurrence and accelerated onset of hepatocellular carcinoma in patients with chronic hepatitis b infection [99].
PubMedID- 24976705 hepatitis b virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy.
PubMedID- 22231575 Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis b virus infection.
PubMedID- 21160979 Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis b.
PubMedID- 23258096 Effect of response to interferon-alpha therapy on the occurrence of hepatocellular carcinoma in patients with chronic hepatitis b.
PubMedID- 21170112 Objective: to compare efficacy of plain and contrast enhancement mri (1.5t or 3t) and dynamic contrast enhanced multidetector ct (mdct, 16- or 64 -slice) for the detection of small hepatocellular carcinoma (hcc) in patients with hepatitis b-induced cirrhosis.
PubMedID- 22946841 The objective of the present study was to explore the common and specific metabolic alterations of hepatocellular carcinoma (hcc) infected with hepatitis b virus (hbv) or hepatitis c virus (hcv).
PubMedID- 22712471 Background: a recent genome-wide association study (gwas) using chronic hbv (hepatitis b virus) carriers with and without hepatocellular carcinoma (hcc) in five independent chinese populations found that one snp (rs17401966) in kif1b was associated with susceptibility to hcc.
PubMedID- 24344773 Combinations of eight key mutations in the x/prec region and genomic activity of hepatitis b virus are associated with hepatocellular carcinoma.
PubMedID- 24316105 Prevention of hepatocellular carcinoma resulting from hepatitis b: are we there yet.
PubMedID- 22972059 Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis b.
PubMedID- 22212935 Prevention of hepatocellular carcinoma in patients with chronic hepatitis b virus infection.
PubMedID- 22957763 A high incidence of tumor recurrence and metastasis has been reported in hepatocellular carcinoma (hcc) patients with chronic hepatitis b virus (hbv) infection.
PubMedID- 24570914 Chemoprevention and novel therapy for hepatocellular carcinoma associated with chronic hepatitis b virus infection.
PubMedID- 24707821 Both multi-tgdr frameworks were used to analyze a metabolomics dataset that compares the metabolic profiles of hepatocellular carcinoma (hcc) infected with hepatitis b (hbv) or c virus (hcv) with that of cirrhosis induced by hbv/hcv infection; the goal was to improve early-stage diagnosis of hcc.
PubMedID- 20652159 Overexpression of cyclooxygenase-2 in noncancerous liver tissue increases the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis b virus-related cirrhosis.
PubMedID- 26357607 Data from the long-term follow-up of patients enrolled in the registration studies showed that treatment with entecavir can lead to significant improvements in liver histopathology, and recent cohort studies have demonstrated that treatment with entecavir may reduce disease progression and the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b.
PubMedID- 25983748 The role of tlr3 in hepatocellular carcinoma (hcc) with hepatitis b virus (hbv) infections is not well understood.

Page: 1 2 3